Accueil >
Publications >
Prognostic value of inflammatory response biomarkers using peripheral blood and [18F]-FDG PET/CT in advanced NSCLC patients treated with first-line chemo- or immunotherapy

Prognostic value of inflammatory response biomarkers using peripheral blood and [18F]-FDG PET/CT in advanced NSCLC patients treated with first-line chemo- or immunotherapy

1 sept. 2021Lung Cancer

DOI : 10.1016/j.lungcan.2021.06.024

Auteurs

Romain-David Seban, Jean-Baptiste Assié, Etienne Giroux-Leprieur, Marie-Ange Massiani, Gérald Bonardel, Christos Chouaid, Nicolas Deleval, Capucine Richard, Laura Mezquita, Nicolas Girard, Laurence Champion